Crystal Structure of Human Cytochrome P450 2D6

Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0Å resolution. The structure sho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2006-03, Vol.281 (11), p.7614-7622
Hauptverfasser: Rowland, Paul, Blaney, Frank E., Smyth, Martin G., Jones, Jo J., Leydon, Vaughan R., Oxbrow, Amanda K., Lewis, Ceri J., Tennant, Mike G., Modi, Sandeep, Eggleston, Drake S., Chenery, Richard J., Bridges, Angela M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7622
container_issue 11
container_start_page 7614
container_title The Journal of biological chemistry
container_volume 281
creator Rowland, Paul
Blaney, Frank E.
Smyth, Martin G.
Jones, Jo J.
Leydon, Vaughan R.
Oxbrow, Amanda K.
Lewis, Ceri J.
Tennant, Mike G.
Modi, Sandeep
Eggleston, Drake S.
Chenery, Richard J.
Bridges, Angela M.
description Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0Å resolution. The structure shows the characteristic P450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9. There are, however, several important differences, the most notable involving the F helix, the F-G loop, the B′helix, β sheet 4, and part of β sheet 1, all of which are situated on the distal face of the protein. The 2D6 structure has a well defined active site cavity above the heme group, containing many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120. The crystal structure helps to explain how Asp-301, Glu-216, and Phe-483 can act as substrate binding residues and suggests that the role of Phe-120 is to control the orientation of the aromatic ring found in most substrates with respect to the heme. The structure has been compared with published homology models and has been used to explain much of the reported site-directed mutagenesis data and help understand the metabolism of several compounds.
doi_str_mv 10.1074/jbc.M511232200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17112998</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819353864</els_id><sourcerecordid>17112998</sourcerecordid><originalsourceid>FETCH-LOGICAL-c465t-93c6808538ee0d0fa51799388e1c2fefb148d2d0fb1182c961f19d414e72879c3</originalsourceid><addsrcrecordid>eNp1kE1L5EAQhhtZ0fHj6lEDC94yVvVH0n1cZnVdUBRU8NYknYrTMplod6LMv7eXDHjautShnnqpehg7QZgjlPLitXbzW4XIBecAO2yGoEUuFD7_YDMAjrnhSu-zgxhfIZU0uMf2sRCKK1PO2HwRNnGoVtnDEEY3jIGyvs2ux65aZ4vN0Ltl6DvK7qWCjP8ujthuW60iHW_7IXu6unxcXOc3d3_-Ln7d5E4WasiNcIUGrYQmggbaSmFpjNCa0PGW2hqlbnga1IiaO1Ngi6aRKKnkujROHLLzKfct9O8jxcF2Pjparao19WO0WKaXjdEJnE-gC32MgVr7FnxXhY1FsP8M2WTIfhtKC6fb5LHuqPnGt0oS8HMClv5l-ekD2donDdRZrtEi2rJAmaiziWqr3lYvwUf79MABBSAUoKVKhJ4ISp4-PAUbnae1oyZlusE2vf_fjV-bA4Wl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17112998</pqid></control><display><type>article</type><title>Crystal Structure of Human Cytochrome P450 2D6</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Rowland, Paul ; Blaney, Frank E. ; Smyth, Martin G. ; Jones, Jo J. ; Leydon, Vaughan R. ; Oxbrow, Amanda K. ; Lewis, Ceri J. ; Tennant, Mike G. ; Modi, Sandeep ; Eggleston, Drake S. ; Chenery, Richard J. ; Bridges, Angela M.</creator><creatorcontrib>Rowland, Paul ; Blaney, Frank E. ; Smyth, Martin G. ; Jones, Jo J. ; Leydon, Vaughan R. ; Oxbrow, Amanda K. ; Lewis, Ceri J. ; Tennant, Mike G. ; Modi, Sandeep ; Eggleston, Drake S. ; Chenery, Richard J. ; Bridges, Angela M.</creatorcontrib><description>Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0Å resolution. The structure shows the characteristic P450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9. There are, however, several important differences, the most notable involving the F helix, the F-G loop, the B′helix, β sheet 4, and part of β sheet 1, all of which are situated on the distal face of the protein. The 2D6 structure has a well defined active site cavity above the heme group, containing many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120. The crystal structure helps to explain how Asp-301, Glu-216, and Phe-483 can act as substrate binding residues and suggests that the role of Phe-120 is to control the orientation of the aromatic ring found in most substrates with respect to the heme. The structure has been compared with published homology models and has been used to explain much of the reported site-directed mutagenesis data and help understand the metabolism of several compounds.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M511232200</identifier><identifier>PMID: 16352597</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Aspartic Acid - chemistry ; Binding Sites ; Carbon Monoxide - chemistry ; Crystallography, X-Ray ; Cytochrome P-450 CYP2D6 - chemistry ; Glutamic Acid - chemistry ; Heme - chemistry ; Humans ; Kinetics ; Models, Molecular ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Mutation ; Protein Conformation ; Protein Folding ; Protein Structure, Secondary ; Protein Structure, Tertiary ; Sequence Homology, Amino Acid ; Software ; Subcellular Fractions ; Substrate Specificity</subject><ispartof>The Journal of biological chemistry, 2006-03, Vol.281 (11), p.7614-7622</ispartof><rights>2006 © 2006 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c465t-93c6808538ee0d0fa51799388e1c2fefb148d2d0fb1182c961f19d414e72879c3</citedby><cites>FETCH-LOGICAL-c465t-93c6808538ee0d0fa51799388e1c2fefb148d2d0fb1182c961f19d414e72879c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16352597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rowland, Paul</creatorcontrib><creatorcontrib>Blaney, Frank E.</creatorcontrib><creatorcontrib>Smyth, Martin G.</creatorcontrib><creatorcontrib>Jones, Jo J.</creatorcontrib><creatorcontrib>Leydon, Vaughan R.</creatorcontrib><creatorcontrib>Oxbrow, Amanda K.</creatorcontrib><creatorcontrib>Lewis, Ceri J.</creatorcontrib><creatorcontrib>Tennant, Mike G.</creatorcontrib><creatorcontrib>Modi, Sandeep</creatorcontrib><creatorcontrib>Eggleston, Drake S.</creatorcontrib><creatorcontrib>Chenery, Richard J.</creatorcontrib><creatorcontrib>Bridges, Angela M.</creatorcontrib><title>Crystal Structure of Human Cytochrome P450 2D6</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0Å resolution. The structure shows the characteristic P450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9. There are, however, several important differences, the most notable involving the F helix, the F-G loop, the B′helix, β sheet 4, and part of β sheet 1, all of which are situated on the distal face of the protein. The 2D6 structure has a well defined active site cavity above the heme group, containing many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120. The crystal structure helps to explain how Asp-301, Glu-216, and Phe-483 can act as substrate binding residues and suggests that the role of Phe-120 is to control the orientation of the aromatic ring found in most substrates with respect to the heme. The structure has been compared with published homology models and has been used to explain much of the reported site-directed mutagenesis data and help understand the metabolism of several compounds.</description><subject>Amino Acid Sequence</subject><subject>Aspartic Acid - chemistry</subject><subject>Binding Sites</subject><subject>Carbon Monoxide - chemistry</subject><subject>Crystallography, X-Ray</subject><subject>Cytochrome P-450 CYP2D6 - chemistry</subject><subject>Glutamic Acid - chemistry</subject><subject>Heme - chemistry</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Models, Molecular</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Mutation</subject><subject>Protein Conformation</subject><subject>Protein Folding</subject><subject>Protein Structure, Secondary</subject><subject>Protein Structure, Tertiary</subject><subject>Sequence Homology, Amino Acid</subject><subject>Software</subject><subject>Subcellular Fractions</subject><subject>Substrate Specificity</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1L5EAQhhtZ0fHj6lEDC94yVvVH0n1cZnVdUBRU8NYknYrTMplod6LMv7eXDHjautShnnqpehg7QZgjlPLitXbzW4XIBecAO2yGoEUuFD7_YDMAjrnhSu-zgxhfIZU0uMf2sRCKK1PO2HwRNnGoVtnDEEY3jIGyvs2ux65aZ4vN0Ltl6DvK7qWCjP8ujthuW60iHW_7IXu6unxcXOc3d3_-Ln7d5E4WasiNcIUGrYQmggbaSmFpjNCa0PGW2hqlbnga1IiaO1Ngi6aRKKnkujROHLLzKfct9O8jxcF2Pjparao19WO0WKaXjdEJnE-gC32MgVr7FnxXhY1FsP8M2WTIfhtKC6fb5LHuqPnGt0oS8HMClv5l-ekD2donDdRZrtEi2rJAmaiziWqr3lYvwUf79MABBSAUoKVKhJ4ISp4-PAUbnae1oyZlusE2vf_fjV-bA4Wl</recordid><startdate>20060317</startdate><enddate>20060317</enddate><creator>Rowland, Paul</creator><creator>Blaney, Frank E.</creator><creator>Smyth, Martin G.</creator><creator>Jones, Jo J.</creator><creator>Leydon, Vaughan R.</creator><creator>Oxbrow, Amanda K.</creator><creator>Lewis, Ceri J.</creator><creator>Tennant, Mike G.</creator><creator>Modi, Sandeep</creator><creator>Eggleston, Drake S.</creator><creator>Chenery, Richard J.</creator><creator>Bridges, Angela M.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20060317</creationdate><title>Crystal Structure of Human Cytochrome P450 2D6</title><author>Rowland, Paul ; Blaney, Frank E. ; Smyth, Martin G. ; Jones, Jo J. ; Leydon, Vaughan R. ; Oxbrow, Amanda K. ; Lewis, Ceri J. ; Tennant, Mike G. ; Modi, Sandeep ; Eggleston, Drake S. ; Chenery, Richard J. ; Bridges, Angela M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c465t-93c6808538ee0d0fa51799388e1c2fefb148d2d0fb1182c961f19d414e72879c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Amino Acid Sequence</topic><topic>Aspartic Acid - chemistry</topic><topic>Binding Sites</topic><topic>Carbon Monoxide - chemistry</topic><topic>Crystallography, X-Ray</topic><topic>Cytochrome P-450 CYP2D6 - chemistry</topic><topic>Glutamic Acid - chemistry</topic><topic>Heme - chemistry</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Models, Molecular</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Mutation</topic><topic>Protein Conformation</topic><topic>Protein Folding</topic><topic>Protein Structure, Secondary</topic><topic>Protein Structure, Tertiary</topic><topic>Sequence Homology, Amino Acid</topic><topic>Software</topic><topic>Subcellular Fractions</topic><topic>Substrate Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rowland, Paul</creatorcontrib><creatorcontrib>Blaney, Frank E.</creatorcontrib><creatorcontrib>Smyth, Martin G.</creatorcontrib><creatorcontrib>Jones, Jo J.</creatorcontrib><creatorcontrib>Leydon, Vaughan R.</creatorcontrib><creatorcontrib>Oxbrow, Amanda K.</creatorcontrib><creatorcontrib>Lewis, Ceri J.</creatorcontrib><creatorcontrib>Tennant, Mike G.</creatorcontrib><creatorcontrib>Modi, Sandeep</creatorcontrib><creatorcontrib>Eggleston, Drake S.</creatorcontrib><creatorcontrib>Chenery, Richard J.</creatorcontrib><creatorcontrib>Bridges, Angela M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rowland, Paul</au><au>Blaney, Frank E.</au><au>Smyth, Martin G.</au><au>Jones, Jo J.</au><au>Leydon, Vaughan R.</au><au>Oxbrow, Amanda K.</au><au>Lewis, Ceri J.</au><au>Tennant, Mike G.</au><au>Modi, Sandeep</au><au>Eggleston, Drake S.</au><au>Chenery, Richard J.</au><au>Bridges, Angela M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Crystal Structure of Human Cytochrome P450 2D6</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2006-03-17</date><risdate>2006</risdate><volume>281</volume><issue>11</issue><spage>7614</spage><epage>7622</epage><pages>7614-7622</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0Å resolution. The structure shows the characteristic P450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9. There are, however, several important differences, the most notable involving the F helix, the F-G loop, the B′helix, β sheet 4, and part of β sheet 1, all of which are situated on the distal face of the protein. The 2D6 structure has a well defined active site cavity above the heme group, containing many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120. The crystal structure helps to explain how Asp-301, Glu-216, and Phe-483 can act as substrate binding residues and suggests that the role of Phe-120 is to control the orientation of the aromatic ring found in most substrates with respect to the heme. The structure has been compared with published homology models and has been used to explain much of the reported site-directed mutagenesis data and help understand the metabolism of several compounds.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16352597</pmid><doi>10.1074/jbc.M511232200</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2006-03, Vol.281 (11), p.7614-7622
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_17112998
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Amino Acid Sequence
Aspartic Acid - chemistry
Binding Sites
Carbon Monoxide - chemistry
Crystallography, X-Ray
Cytochrome P-450 CYP2D6 - chemistry
Glutamic Acid - chemistry
Heme - chemistry
Humans
Kinetics
Models, Molecular
Molecular Sequence Data
Mutagenesis, Site-Directed
Mutation
Protein Conformation
Protein Folding
Protein Structure, Secondary
Protein Structure, Tertiary
Sequence Homology, Amino Acid
Software
Subcellular Fractions
Substrate Specificity
title Crystal Structure of Human Cytochrome P450 2D6
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T11%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Crystal%20Structure%20of%20Human%20Cytochrome%20P450%202D6&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Rowland,%20Paul&rft.date=2006-03-17&rft.volume=281&rft.issue=11&rft.spage=7614&rft.epage=7622&rft.pages=7614-7622&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M511232200&rft_dat=%3Cproquest_cross%3E17112998%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17112998&rft_id=info:pmid/16352597&rft_els_id=S0021925819353864&rfr_iscdi=true